Features of the endothelial status in patients with gastric cancer and its impact on surgical treatment outcomes

Abstract

BACKGROUND: The incidence of gastric cancer is still high and holds the leading place in the structure of oncological pathology in the world. Prognostic aspects in the treatment of generalized forms of gastric cancer are currently under revision.

AIM: To study functional status of vascular endothelium in patients with gastric cancer in perioperative period and evaluate its influence on the outcomes of surgical treatment.

MATERIALS AND METHODS: A prospective, randomized study was conducted from 2009 to 2019. Two populations were studied: healthy individuals (control group, n=40); patients diagnosed with gastric cancer (general group, n=122). Patients with gastric cancer underwent gastrectomy with lymphodissection.

The functional state of the vascular endothelium was studied: the volume of circulating endotheliocytes (CCE); the level of von Willebrand factor (VF) and the degree of endothelium-dependent vasodilation (EDV). To study their prognostic significance we calculated a conventional “cut-off point”.

RESULTS: The general group patients were divided into 2 subgroups: the main group — the laparoscopic access (n=54) and the comparison group — the laparotomy access (n=68).

Endothelial dysfunction (EDF) correction with Glutargin 1.0 g per day in combination with Enalapril 2.5 mg per day was additionally used in the main subgroup.

In the main group, the values of CCE and VF were lower (8.3±3.0 and 84.6±21.3, respectively) and the values of EDV were higher (13.7±3.9) in contrast to the comparison group (p <0.0001).

Use of the EDF correction method in the main group resulted in a 4.4-fold and 5.1-fold decrease in CCE and VF concentrations, respectively, and a 4.3-fold normalization of EDV (p <0.0001). Increase of CCE concentration more than 7.0 per 10³ platelets; PV more than 120 μg/ml, as well as decrease of EDV below 14% in the study stages increased the risk of postoperative complications by 2.9; 1.7 and 1.8 times, respectively (p <0.0001).

The incidence of surgical complications was 19.7% and non-surgical complications 31.1%. Hospital mortality was 3.3% and out-of-hospital mortality with up to three years follow-up was 13.1%.

The number of purulent-septic complications in the main group was 2.9 times lower, and the rate of thrombotic complications was 4 times lower than in the comparison group (p <0.05).

CONCLUSION: Combined use of laparoscopic technique by EDF medication correction reduces manifestations of stress reaction and decreases the potential risk of complications development in the postoperative period. Elevation of CCE, as well as EDV decrease beyond the relevant excision points in patients with gastric cancer in the perioperative period are prognostic predictors of the risk of purulent-septic and thrombotic complications development.

Keywords

stomach neoplasms / surgical procedures / endothelium / postoperative complications / von Willebrand factor

References

[1] Kit OI, Samoylenko NS, Frantsiyants EM. Gastric cancer: modern directions in basic research. Modern problems of science and education. 2019;(4):136. Режим доступа: https://www.elibrary.ru/item.asp?id=39251305 (In Russ).

[2] Кит О.И., Самойленко Н.С., Франциянц Е.М., и др. Рак желудка: Современные направления фундаментальных исследований // Современные проблемы науки и образования. 2019. № 4. С. 136. Режим доступа: https://www.elibrary.ru/item.asp?id=39251305

[3] Khedmat H, Panahian M, Mashahdian M, et al. Prognostic factors and survival in stomach cancer — analysis of 15 years of data from a referral hospital in Iran and evaluation of international variation. Oncology. 2011;34(4):178–182. doi: 10.1159/000327007

[4] Khedmat H., Panahian M., Mashahdian M., et al. Prognostic factors and survival in stomach cancer — analysis of 15 years of data from a referral hospital in Iran and evaluation of international variation // Oncology. 2011. Vol. 34, N 4. P. 178–182. doi: 10.1159/000327007

[5] Nashimoto A, Akazawa K, Isobe Y, et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2013;16(1):1–27. doi: 10.1007/s10120-012-0163-4

[6] Nashimoto A., Akazawa K., Isobe Y., et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry // Gastric Cancer. 2013. Vol. 16, N 1. P. 1–27. doi: 10.1007/s10120-012-0163-4

[7] Tkach SM. Infekcija H. pylori kak osnovnaja prichina zheludochnogo kancerogeneza. Zdorov’ja Ukraïni. 2009;1:32–33. (In Russ).

[8] Ткач С.М. Инфекция H. pylori как основная причина желудочного канцерогенеза // Здоров’я Украïни. 2009. Т. 1. С. 32–33.

[9] Isobe Y, Nashimoto A, Akazawa K, et al. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer. 2011;14(4):301–316. doi: 10.1007/s10120-011-0085-6

[10] Isobe Y., Nashimoto A., Akazawa K., et al. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry // Gastric Cancer. 2011. Vol. 14, N 4. P. 301–316. doi: 10.1007/s10120-011-0085-6

[11] Hwang IR, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin-1 beta production in Helicobacter pylori infection. Gastroenterology. 2002;123(6):1793–1803. doi: 10.1053/gast.2002.37043

[12] Hwang I.R., Kodama T., Kikuchi S., et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin-1 beta production in Helicobacter pylori infection // Gastroenterology. 2002. Vol. 123, N 6. P. 1793–1803. doi: 10.1053/gast.2002.37043

[13] MacLennan GT, Eisenberg R, Fleshman RL, et al. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year follow-up study. J Urol. 2006;176:1012–1016. doi: 10.1016/j.juro.2006.04.033

[14] MacLennan G.T., Eisenberg R., Fleshman R.L., et al. The influence of chronic inflammation in prostatic carcinogenesis: a 5-year follow-up study // J Urol. 2006. Vol. 176, N 3. P. 1012–1016. doi: 10.1016/j.juro.2006.04.033

[15] Robertson FM, Cristofanilli M. A global approach to inflammatory breast cancer. Future Oncol. 2011;7(1):25–30. doi: 10.2217/fon.10.177

[16] Robertson F.M., Cristofanilli M. A global approach to inflammatory breast cancer // Future Oncol. 2011. Vol. 7, N 1. P. 25–30. doi: 10.2217/fon.10.177

[17] Pollard JW. Trophic macrophages in development and disease. Nat Rev Immunol. 2009;9(4):259–270. doi: 10.1038/nri2528

[18] Pollard J.W. Trophic macrophages in development and disease. Nat Rev Immunol. 2009. Vol. 9, N 4. P. 259–270. doi: 10.1038/nri2528

[19] Eiró N, Vizoso FJ. Inflammation and cancer. World J Gastrointest Surg. 2012;4(3):62–72. doi: 10.4240/wjgs.v4.i3.62

[20] Eiró N., Vizoso F.J. Inflammation and cancer // World J Gastrointest Surg. 2012. Vol. 4, N 3. P. 62–72. doi: 10.4240/wjgs.v4.i3.62

[21] Huang SP, Wu MS, Shun CT, et al. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. J Biomed Sci. 2005;12(1):229–241. doi: 10.1007/s11373-004-8177-5

[22] Huang S.P., Wu M.S., Shun C.T., et al. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma // J Biomed Sci. 2005. Vol. 12, N 1. P. 229–241. doi: 10.1007/s11373-004-8177-5

[23] Läubli H, Borsig L. Selectins promote tumor metastasis. Semin Cancer Biol. 2010;20(3):169–177. doi: 10.1016/j.semcancer.2010.04.005

[24] Läubli H., Borsig L. Selectins promote tumor metastasis // Semin Cancer Biol. 2010. Vol. 20, N 3. P. 169–177. doi: 10.1016/j.semcancer.2010.04.005

[25] Geng Y, Chandrasekaran S, Hsu JW, et al. Phenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesion. PLoS One. 2013;8(1):e54959. doi: 10.1371/journal.pone.0054959

[26] Geng Y., Chandrasekaran S., Hsu J.W., et al. Phenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesion // PLoS One. 2013. Vol. 8, N 1. P. e54959. doi: 10.1371/journal.pone.0054959

[27] Robinson SC, Scott KA, Balkwill FR. Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF alpha. Eur J Immunol. 2002;32:404–412. doi: 10.1002/1521-4141(200202)32:2<404::AID-IMMU404>3.0.CO;2-X

[28] Robinson S.C., Scott K.A., Balkwill F.R. Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF alpha // Eur J Immunol. 2002. Vol. 32. P. 404–412. doi: 10.1002/1521-4141(200202)32:2<404::AID-IMMU404>3.0.CO;2-X

[29] Soboleva GN, Fedulov VK, Samko AN, et al. Prognostic value of endothelial dysfunction in coronary and brachial arteries, and common risk factors in development of cardiovascular complications in patients with microvascular angina. Russian Journal of Cardiology. 2017;22(3):54–58. (In Russ). doi: 10.15829/1560-4071-2017-3-54-58

[30] Соболева Г.Н., Федулов В.К., Самко А.Н., и др. Прогностическое значение дисфункции эндотелия коронарных и плечевой артерии, традиционных факторов риска в развитии сердечно-сосудистых осложнений у пациентов с микрососудистой стенокардией // Российский кардиологический журнал. 2017. Т. 22, № 3. С. 54–58. doi: 10.15829/1560-4071-2017-3-54-58

[31] Celermajer D, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340(8828):1111–1115. doi: 10.1016/0140-6736(92)93147-f

[32] Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis // Lancet. 1992. Vol. 340. N 8828. P. 1111–1115. doi: 10.1016/0140-6736(92)93147-f

[33] Zateyshchikova AA, Zateyshchikov DA. Endothelial regulation of vascular tone: research methods and clinical significance. Kardiologiia. 1998;38(9):68–80.

[34] Zateyshchikova A.A., Zateyshchikov D.A. Endothelial regulation of vascular tone: research methods and clinical significance // Kardiologiia. 1998. Vol. 38, N 9. P. 68–80.

[35] Accini JL, Sotomayor A, Trujillo F, et al. Colombian study to assess the use of noninvasive determination of endothelium mediated vasodilatation (CANDEV): normal values and factors associated. Endothelium. 2001;8(2):157–166. doi: 10.3109/10623320109165324

[36] Accini J.L., Sotomayor A., Trujillo F., et al. Colombian study to assess the use of noninvasive determination of endothelium mediated vasodilatation (CANDEV). Normal values and factors associated // Endothelium. 2001. Vol. 8, N 2. P. 157–166. doi: 10.3109/10623320109165324

[37] Hladovec J. Circulating endothelial cells as sign of vessels wall lesions. Physiol Bohemoslov. 1978;27(2):140–144.

[38] Hladovec J. Circulating endothelial cells as sign of vessels wall lesions // Physiol Bohemoslov. 1978. Vol. 27, N 2. Р. 140–144.

[39] Petrishhev HH, Berkovich OA, Vlasov TD, et al. Diagnosticheskaja cennost’ opredelenija deskvamirovannyh jendotelial’nyh kletok v krovi. Klinicheskaja laboratornaja diagnostika. 2001;(1):50–52. (In Russ).

[40] Петрищев H.H., Беркович О.А., Власов Т.Д., и др. Диагностическая ценность определения десквамированных эндотелиальных клеток в крови // Клиническая лабораторная диагностика. 2001. № 1. С. 50–52.

[41] Kozlovskij VI, Solodkov AP, Mjadelec OD, Akuljonok AV. Metody opredelenija chisla cirkulirujushhih v krovi jendoteliocitov: metodicheskie rekomendacii. Vitebsk; 2008. P. 29. (In Russ).

[42] Козловский В.И., Солодков А.П., Мяделец О.Д., Акулёнок А.В. Методы определения числа циркулирующих в крови эндотелиоцитов : методические рекомендации. Витебск, 2008. С. 29.

[43] Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194:927–929. doi: 10.1038/194927b0

[44] Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal // Nature. 1962. Vol. 194. P. 927–929. doi: 10.1038/194927b0

[45] Makarova NV. Statisticheskij analiz mediko-biologicheskih dannyh s ispol’zovanie paketov statisticheskih programm Statictica, SPSS, NCSS, SYSTAT: metodicheskoe posobie. Vserossijskij centr jekstrennoj i radiacionnoj mediciny im. A.M. Nikiforova MChS Rossii. Sankt-Peterburg: Politehnika-servis; 2012. 178 p. (In Russ).

[46] Макарова Н.В. Статистический анализ медико-биологических данных с использование пакетов статистических программ Statictica, SPSS, NCSS, SYSTAT : методическое пособие. Всероссийский центр экстренной и радиационной медицины им. А.М. Никифорова МЧС России. Санкт-Петербург : Политехника-сервис, 2012. 178 с.

[47] Altman DG, editor. Practical statistics for medical research. Chapman & Hall; 2018. 624 p.

[48] Practical statistics for medical research / D.G. Altman, editor. Chapman & Hall, 2018. 624 p.

RIGHTS & PERMISSIONS

Eco-Vector